Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Project 4: ACHIEVE PATHFINDER
for
Heart Failure
Location: Detroit MI
Sponsor: Henry Ford Health System
Sex: All
Age: 18+
Code: NCT06070428
Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Boston MA, Richmond VA, Durham NC, Pittsburgh PA,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06619561
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
for
Persistent Corneal Epithelial Defect
Location: Palisades Park NJ, Bala-Cynwyd PA, South Miami FL,
Sponsor: Glaukos Corporation
Sex: All
Age: 2+
Code: NCT05966493
Phase 2, Recruiting
Study of Efficacy of the MyoTrain System in a Population of Individuals With Trans-radial Limb Loss
for
Amputation, Upper Limb
Location: Grand Rapids MI
Sponsor: Infinite Biomedical Technologies
Sex: All
Age: 18+
Code: NCT05888428
Recruiting
Abatacept in Immune Checkpoint Inhibitor Myocarditis
for
Myocarditis Acute, Cancer
Location: Portland ME, Boston MA, New York NY, New Brunswick NJ,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05335928
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Boston MA, Stoneham MA, Westerly RI, Waterford CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase 3, Recruiting
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
for
Advanced NRAS-Mutant Melanoma,
Location: Boston MA, New York NY, Fairfax VA, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07584226
Phase 1, Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department
for
Back Pain, Chronic Pain
Location: Kalamazoo MI
Sponsor: Western Michigan University School of Medicine
Sex: All
Age: 18 - 65
Code: NCT06395428
Recruiting
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
for
Cardiotoxicity, HER2/Neu Positive,
Location: Winchester MA, Burlington MA, White Plains NY, Nyack NY,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT03418961
Phase 3, Recruiting
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
for
MTAP-deleted Solid Tumors
Location: Boston MA, New York NY, Orlando FL, Grand Rapids MI,
Sponsor: Bayer
Sex: All
Age: 18+
Code: NCT06914128
Phase 1, Phase 2, Recruiting
Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival
for
Peripheral Intravenous Vein Catheter Phlebitis,
Location: Royal Oak MI
Sponsor: Corewell Health East
Sex: All
Age: 18+
Code: NCT06107361
Recruiting
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
for
Solid Tumor, Sarcoma, Leiomyosarcoma,
Location: Boston MA, Lake Success NY, Fairfax VA, Cleveland OH,
Sponsor: STORM Therapeutics LTD
Sex: All
Age: 18+
Code: NCT06975293
Phase 1, Phase 2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Halifax, Portland ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase 2, Recruiting
MIVetsCan: Cannabidiol (CBD)-Care Trial
for
Pain, Chronic
Location: Ann Arbor MI
Sponsor: Kevin Boehnke
Sex: All
Age: 18+
Code: NCT06213233
Phase 2, Recruiting
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: St. John's, Rimouski, Boston MA, Levis, Stony Brook NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase 3, Recruiting
Mechanisms of Fatigability With Diabetes
for
Pre-diabetes, Type 2 Diabetes
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 30 - 70+
Code: NCT04442451
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
for
Narcolepsy Type 1
Location: Miami FL, Markham, Toronto, Winter Park FL,
Sponsor: Alkermes, Inc.
Sex: All
Age: 18 - 70
Code: NCT07540897
Phase 3, Recruiting
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
for
Ewing Sarcoma, Colorectal Adenocarcinoma
Location: New York NY, Philadelphia PA, Fairfax VA,
Sponsor: Inhibrx Biosciences, Inc
Sex: All
Age: 12 - 70+
Code: NCT03715933
Phase 1, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations